Could the next thing you read here change your life?

There’s news. And then there’s news. The news that comes out of the Naomi Berrie Diabetes Center can change lives. For people with diabetes and those who care for them, and about them. So it makes sense to stay on top of all the latest — with both Berrie Center Direct news and In the Headlines, the frequent media coverage we get based on our important and exciting findings and the authoritative voices that speak for us.

Go To: In The Headlines

Berrie Center Direct

There’s always something going on here at the Naomi Berrie Diabetes Center. Promising research. Special events. Success stories from our patients and their families. Stop by often to see the latest.

Click on the links below to see what’s happening at the Berrie Center.


Diabetes Stem Cell Research Update

Berrie Center Scientists Use Patient-Specific Stem Cells to Correct Deficient Beta Cells

Ten scientists and physicians from the Naomi Berrie Diabetes Center recently collaborated with the New York Stem Cell Foundation to generate patient-specific beta cells, or insulin-producing cells, that accurately reflect the features of maturity-onset diabetes of the young (MODY). 


Clinical Profile: Rachelle Gandica, MD

A Rising Star

She dreamed of becoming an astronaut as a girl growing up in southern New Jersey. Instead, she followed her fascination in science into medicine rather than space—and today (in what was clearly a loss for NASA) Rachelle Gandica, MD, is a pediatric endocrinologist and a rising star at the Naomi Berrie Diabetes Center. 


A 50th Wedding Anniversary:

A Golden Gift for the Berrie Center

What do you get the couple who has everything?  On the occasion of their Golden Wedding Anniversary, the Honorable Marvin E. and Carole Segal asked friends and family to consider a gift that reflected the same love and commitment that kept them a couple for half a century.


The GRADE Study

Recruitment begins for important new type 2 diabetes study

The Naomi Berrie Diabetes Center is now looking for volunteers to take part in an NIH study to compare the long-term benefits and risks of four widely used diabetes drugs in combination with metformin, the most common first-line medication for treating type 2 diabetes.


On the Run with Stephen England

Athlete Defies the Odds

Since we last left runner Stephen England he has added at least a dozen races—including two, 50-mile ultra-marathons—to his already impressive running resume.


Clinician Profile: Daniel Casper, MD, PhD

An Ophthalmologist and Artist

He took an unusual path to Columbia University’s Naomi Berrie Diabetes Center, where he has been the Director of Ophthalmology for the past 12 years. “I have always been a visual person,” said Daniel Casper, MD, PhD, Associate Clinical Professor of Ophthalmology at Columbia University College of Physicians and Surgeons.

Pages